Literature DB >> 26045843

Combined effect of tnf-α polymorphisms and hypoxia on steroid-induced osteonecrosis of femoral head.

Yaosheng Liu1, Weihao Jiang1, Shubin Liu1, Xiuyun Su1, Shiguo Zhou2.   

Abstract

OBJECTIVE: Tumor necrosis factor (TNF)-α is a proinflammatory cytokine, some studies reported that TNF-α gene plays important role in the pathogenesis of SONFH. And the polymorphisms of TNF-α were presented as risk factors for steroid-induced osteonecrosis of the femoral head (SONFH). Meanwhile, various environment factors involve in the pathogenesis of SONFH. Our study aimed to investigate the interaction effect of TNF-α polymorphisms and hypoxia factor on SONFH.
METHODS: 120 patients with SONFH and 100 healthy people, matched with the cases on age and sex, participated in this study. DNA was extracted from all participants. According to previous studies, genotyping of TNF-α polymorphisms (rs1800629, rs1799964 and rs1800630) was tested with the method of PCR-RDB (Reverse Dot Blot). Environmental factors were also chose. Logistic regression analysis was used to analyze the interaction between TNF-α polymorphisms and environment factors on SONFH.
RESULTS: The polymorphisms of rs1800629 and rs1800630 were significantly associated with SONFH (OR: 3.70, 9.93). Patients with hypoxia history were found higher (65.00%) compared with the healthy controls (43.00%). For the person with hypoxic history, GG and AG+AA genotypes of rs1800629 could increase their risk to suffer SONFH (OR: 2.12, 3.78). If the patients with the variant genotypes of rs1800630 experienced hypoxia state, then the risk for SONFH increased 2.41 folds.
CONCLUSION: We concluded that the onset of SONFH was influenced by TNF-α and hypoxia history. There existed strong interaction between TNF-α and hypoxia history.

Entities:  

Keywords:  TNF-α; hypoxia; osteonecrosis of the femoral head; polymorphism; steroid

Mesh:

Substances:

Year:  2015        PMID: 26045843      PMCID: PMC4440152     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

Review 1.  Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals.

Authors:  C Patil; P Walter
Journal:  Curr Opin Cell Biol       Date:  2001-06       Impact factor: 8.382

Review 2.  Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls.

Authors:  R J Kaufman
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

3.  Inflammatory cytokines regulate proliferation of cultured human osteoblasts.

Authors:  A Frost; K B Jonsson; O Nilsson; O Ljunggren
Journal:  Acta Orthop Scand       Date:  1997-04

4.  [Research methods in stresses appearing in bone after osteosynthesis].

Authors:  P Opdecam; P Halleux; L Coutelier; P Blaimont
Journal:  Acta Orthop Belg       Date:  1974       Impact factor: 0.500

5.  Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C.

Authors:  C-Y Dai; W-L Chuang; L-P Lee; S-C Chen; N-J Hou; Z-Y Lin; M-Y Hsieh; M-Y Hsieh; L-Y Wang; W-Y Chang; M-L Yu
Journal:  J Viral Hepat       Date:  2006-11       Impact factor: 3.728

Review 6.  Non-traumatic avascular necrosis of the femoral head.

Authors:  M A Mont; D S Hungerford
Journal:  J Bone Joint Surg Am       Date:  1995-03       Impact factor: 5.284

7.  Hypoxia enhances glucocorticoid-induced apoptosis and cell cycle arrest via the PI3K/Akt signaling pathway in osteoblastic cells.

Authors:  Wanjing Zou; Shu Yang; Tie Zhang; Haimei Sun; Yuying Wang; Hong Xue; Deshan Zhou
Journal:  J Bone Miner Metab       Date:  2014-09-18       Impact factor: 2.626

Review 8.  What's new in the role of cytokines on osteoblast proliferation and differentiation?

Authors:  M H Zheng; D J Wood; J M Papadimitriou
Journal:  Pathol Res Pract       Date:  1992-12       Impact factor: 3.250

Review 9.  The role of interleukin-1 in bone resorption in rheumatoid arthritis.

Authors:  V Strand; A F Kavanaugh
Journal:  Rheumatology (Oxford)       Date:  2004-06       Impact factor: 7.580

10.  Predictive role of cytokine gene polymorphisms for the development of femoral head osteonecrosis.

Authors:  S Samara; P Kollia; Z Dailiana; C Chassanidis; L Papatheodorou; T Koromila; K N Malizos
Journal:  Dis Markers       Date:  2012       Impact factor: 3.434

View more
  5 in total

Review 1.  Association of TNF-α-308(G/A) and -238(G/A) polymorphisms with non-traumatic osteonecrosis of the femoral head risks: a meta-analysis.

Authors:  Yizhong Peng; Yuenan Liu; Donghua Huang; Wei Huang; Zengwu Shao
Journal:  Int Orthop       Date:  2018-03-07       Impact factor: 3.075

Review 2.  Association of Specific Genetic Polymorphisms with Atraumatic Osteonecrosis of the Femoral Head: A Narrative Review.

Authors:  Prasoon Kumar; Pratik M Rathod; Sameer Aggarwal; Sandeep Patel; Vishal Kumar; Karan Jindal
Journal:  Indian J Orthop       Date:  2022-01-06       Impact factor: 1.033

3.  Condemned or Not to Die? Gene Polymorphisms Associated With Cell Death in Pemphigus Foliaceus.

Authors:  Valéria Bumiller-Bini; Gabriel Adelman Cipolla; Mariana Basso Spadoni; Danillo Gardenal Augusto; Maria Luiza Petzl-Erler; Marcia Holsbach Beltrame; Angelica Beate Winter Boldt
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

4.  Involvement of tumor necrosis factor alpha in steroid-associated osteonecrosis of the femoral head: friend or foe?

Authors:  Bin Fang; Ding Wang; Jiaqian Zheng; Qiushi Wei; Dongxiang Zhan; Yamei Liu; Xuesong Yang; Haibin Wang; Gang Li; Wei He; Liangliang Xu
Journal:  Stem Cell Res Ther       Date:  2019-01-03       Impact factor: 6.832

5.  Integrating Transcriptome-Wide Association Study and mRNA Expression Profiling Identifies Novel Genes Associated With Osteonecrosis of the Femoral Head.

Authors:  Mei Ma; Peilin Li; Li Liu; Shiqiang Cheng; Bolun Cheng; Chu Jun Liang; Sijia Tan; Wenyu Li; Yan Wen; Xiong Guo; Cuiyan Wu
Journal:  Front Genet       Date:  2021-06-07       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.